explore -WSS

explore

author：Wikipedia 2025-09-27 12:58:04 - browse：1832

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Helping hospitals and community health centers plan for resilience

hotspot

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Bird flu in dairy cattle: New measures to control spread to humans

Helping hospitals and community health centers plan for resilience

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Readout LOUD podcast: Live from STAT Breakthrough Summit West

focus

explore

focus

ChatGPT in medicine: STAT answers readers' burning questions

HIV vaccine remains elusive. Immunologists keep trying new ideas

BioMarin wins approval for gene therapy to treat hemophilia A

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Medicare proposal to cover medical devices draws a mixed reaction

Hundreds died while taking an arthritis drug, but nobody alerted patients

In Memoriam: Notable people who died in 2023

Study: Black kids more likely to die after surgery than white kids

Activists slam private health insurers over coverage restrictions

With measles on the rise, a personal story of a devastating disease

hotspot

Bird flu reported in person exposed to presumably infected cattle

U.K. decision on ALS drug has neurologists, advocates up in arms

Pancreatic cancer is often deadly, but new discoveries are raising hope

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Arc Institute generative AI designs new CRISPR systems

First Opinion on colorectal cancer screening: letter and response

hotspot

focus

explore

Wikipedia